GRAFTECH INTERNATIONAL LTD Q3 FY2026 earnings call

• Pricing Momentum: Management reports securing customer commitments at significantly higher price levels in Q3 and early Q4, reinforcing confidence in an inflection point for realized pricing. A mid-single-digit percentage increase in realized pricing is expected in Q4 2026, with a more substantial step-change anticipated in 2027.
• Manufacturing Optimization: Announced the planned closure of the Monterrey, Mexico facility due to it being the highest-cost asset in the portfolio. Production will transition to facilities in Calais, France, and Pamplona, Spain. This move aims to improve cost structure, operational efficiency, and reduce capital requirements.
• Cost Reduction Initiatives: Cash cost of goods sold (COGS) per metric ton declined approximately 4% year-over-year in Q3. Management expects a low single-digit percentage decline in full-year 2026 COGS compared to 2025. The Monterrey closure is expected to yield annual cash cost savings of $20–$25 million by 2028.
• Market Fundamentals: Global steel production outside China is showing improving trends. Demand for graphite electrodes is supported by the transition to electric arc furnace steelmaking and infrastructure/defense spending. Needle coke prices have risen to the $1,700–$2,000 per metric ton range due to high raw material costs and supply/demand dynamics.
• Strategic Partnerships: Announced a collaboration with Antora Energy to leverage St. Mary’s, Pennsylvania facility capabilities for thermal battery applications, diversifying into energy storage and industrial defense markets.
• Safety Performance: Total recordable incident rate was 0.47 for the first nine months of 2026, remaining substantially below historical levels despite being above full-year 2025 performance.

The company operates primarily in the graphite electrode and petroleum needle coke segments. For the third quarter of 2026, net sales were $140 million, representing a decline of approximately 3% compared to the prior year period. This decrease was primarily driven by lower weighted average realized graphite electrode pricing, which stood at approximately $3,900 per metric ton (down ~7% year-over-year). The specific revenue contribution percentage for each segment is not explicitly detailed in the transcript; however, the financial results are dominated by the graphite electrode business, with needle coke serving as both a feedstock input and a separate product line benefiting from rising prices.

• Q4 2026 Realized Pricing: Expects a mid-single-digit percentage increase in weighted average realized graphite electrode pricing compared to Q3 2026.
• 2027 Outlook: Anticipates meaningful improvement and a step-change in realized pricing as new contracts negotiated post-September price increases flow through. Confidence remains high that these increases will be margin accretive despite inflationary pressures on energy and decant oil.
• Full-Year 2026 Sales Volume: Maintains expectation for sales volume growth between 5% and 10% compared to the first nine months of 2025.
• Full-Year 2026 COGS: Expects a low single-digit percentage decline in cash cost of goods sold per metric ton compared to 2025.
• Capital Expenditures: Maintaining guidance for approximately $35 million in capital expenditures for the full year 2026.
• Monterrey Closure Benefits: Anticipates annual cash cost savings of $20–$25 million and a reduction in annual capital expenditure requirements of ~$5 million starting in 2027, with full benefits realized in 2028. One-time closure costs of $20–$25 million are expected by end of 2027.

• Raw Material Inflation: Rising costs for decant oil (key needle coke feedstock) and energy inputs pose ongoing margin pressure, though partially offset by blending capabilities and European energy hedging.
• Trade Policy Uncertainty: Disappointment with preliminary anti-dumping determinations from the U.S. Department of Commerce regarding Chinese and Indian imports; final determination expected in Q1 2027, with risks of unfavorable outcomes affecting competitive positioning.
• Supply Chain Disruptions: Ongoing uncertainty affecting Asian producers and oil market disruptions (e.g., Middle East tensions) impacting decant oil availability and pricing.
• Execution Risk: Successful transition of production from Monterrey to European facilities without disrupting customer supply or safety standards.
• Market Volatility: Industry overcapacity remains a risk, although management believes supply reductions and demand growth will help balance the market.

Q: Bennett Moore (JP Morgan) asked about the nature of customer negotiations for recent price hikes and whether they would remain margin accretive given rising EU energy and decant oil costs. / A: CEO Tim Flanagan explained that after an initial 15% uplift announcement, a further 30% increase was announced in September, initiating bespoke negotiations with customers. He expressed confidence that the landed prices in 2027 will be margin accretive, as past cost reductions and ongoing efficiency improvements will more than offset inflationary headwinds in energy and raw materials. CFO Rory O'Donnell added that European energy hedging provides protection against volatility, and supplier diversification helps manage decant oil costs.

Q: Bennett Moore inquired why the Monterrey facility was chosen for closure despite its proximity to the U.S. market, questioning if it was counterintuitive. / A: CEO Flanagan clarified that Monterrey was selected because it is the smallest and highest-cost facility in the portfolio. He noted that U.S. customers are already largely served by European facilities and St. Mary’s, so the transition does not disrupt the supply chain. The decision prioritizes optimizing fixed costs and maintaining product quality while ensuring a seamless transition for customers.

Q: Arun Viswanathan (RBC Capital Markets) asked about global industry utilization rates and whether GrafTech could divert needle coke capacity to EV/battery markets after closing electrode finishing capacity. / A: Flanagan estimated global industry utilization outside China at approximately 65%, suggesting room for further supply tightening as demand grows ~3% annually. Regarding needle coke, he confirmed that reducing electrode capacity frees up assets at the Seadrift facility, allowing the company to explore partnerships for supplying needle coke to broader synthetic graphite applications, including EVs and energy storage, citing the Antora collaboration as an early example.

Q: Abe Landa (Bank of America) sought clarification on the composition of the $20–$25 million one-time closure costs and the split between cash/non-cash and COGS/SG&A. / A: CFO O’Donnell stated the $20–$25 million represents cash costs, predominantly allocated to Cost of Goods Sold (COGS), split roughly half between general closure costs and employee severance. He clarified this is distinct from the $20–$25 million in annual cost savings expected from 2028 onwards, which also primarily benefit COGS. No long-term liability cleanup costs are included in the one-time figure.

Q: Abe Landa asked how the preliminary U.S. anti-dumping duties on Indian imports might impact US import volumes and domestic pricing. / A: CEO Flanagan acknowledged disappointment with the preliminary outcome but emphasized the investigation is incomplete, with final rulings expected in Q1 2027. He noted that Indian competitors hold only 10–15% of the US market. He expressed confidence in GrafTech’s position, arguing that customers value reliable, high-quality supply over the lowest price, suggesting the impact on overall market dynamics may be limited once final protections are implemented.